PROKIDNEY CORP.

Analyst Reco. ProKidney Corp.

Equities

PROK

KYG7S53R1049

End-of-day quote Nasdaq Other stock markets 18:00:00 2024-05-07 EDT			5-day change	1st Jan Change
2.42 ^USD	+1.26%		+12.56%	+35.96%

03-25	ProKidney Corp. Announces Key Leadership Appointments Strengthening Clinical and Technical Operations	CI
03-22	ProKidney Posts Wider 2023 Loss	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

BofA Securities Downgrades ProKidney to Neutral From Buy, Cuts Price Target to $2 From $8	01-02	MT
BTIG Initiates ProKidney With Buy Rating, $16 Price Target	23-07-25	MT
Jefferies Initiates ProKidney With Buy Rating, Price Target is $15	22-12-21	MT
Morgan Stanley Starts ProKidney at Equalweight With $13 Price Target	22-11-10	MT
UBS Initiates Coverage on ProKidney With Buy Rating, $18 Price Target	22-10-18	MT
Citigroup Starts ProKidney at Buy With $16 Price Target	22-10-14	MT
BofA Securities Starts ProKidney at Buy With $14 Price Target	22-09-23	MT
Evercore ISI Initiates Coverage on ProKidney With Outperform Rating	22-09-02	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW